Stocks ended lower Tuesday, snapping a four-day winning streak for major indexes, as investors weighed separate setbacks in trials for a COVID-19 vaccine and a treatment and sifted through earnings for big Wall Street banks. The Dow Jones Industrial Average fell around 157 points, or 0.5%, to end near 28,681, while the S&P 500 gave up around 22 points, or 0.6%, finishing near 3,512. The Nasdaq Composite closed near 11,864, down 97 points, or 0.8%. Shares of Johnson & Johnson (JNJ) fell 2.9% after Stat News reported that the drug maker had paused its COVID-19 vaccine trial over an "unexplained illness." Later Tuesday, Eli Lilly & Co. (LLY) confirmed that a data safety monitoring board had paused enrollment in a clinical study ( ) testing its experimental COVID-19 monoclonal antibody treatment in combination with Gilead Sciences Inc.'s (GILD) remdesivir. Eli Lilly shares ended 2.9% lower.
-William Watts; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
October 13, 2020 16:08 ET (20:08 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.